Collagen Supplements for Skin and Joints: What Clinical Trials Show

Guide

Collagen Supplements for Skin and Joints: What Clinical Trials Show

November 1, 2026 Ā· Researched and written with AI.

Collagen is the most abundant structural protein in the human body, providing strength and elasticity to skin, cartilage, and connective tissues. As natural collagen production slows with age, powders and capsules featuring collagen peptides have become a standard fixture on supplement shelves.

Shoppers often encounter sweeping claims about what these products can accomplish for fine lines, firmness, and aching knees. Because intact collagen is difficult for the digestive system to absorb as a whole molecule, manufacturers use hydrolyzed collagenā€”also called bioactive collagen peptidesā€”which breaks the protein into shorter amino acid chains. Here is a look at what recent randomized controlled trials and scientific reviews actually found regarding how collagen peptides perform in human testing.

What Clinical Trials Show for Skin Health

Skin appearance and barrier function depend heavily on the extracellular matrix in the dermis, where collagen and elastin fibers maintain structural integrity. Several controlled trials have evaluated whether taking collagen peptides by mouth creates measurable changes in skin properties.

In a 2026 narrative review published in Clinical, Cosmetic and Investigational Dermatology, researchers analyzed the available human data on oral collagen peptides and skin biophysical parameters. The review observed that oral peptides consistently showed improvements across several functional measures, including:

Laboratory findings in the review suggested that peptides help stimulate fibroblast proliferation, encourage the synthesis of new collagen and hyaluronic acid, and support natural skin lipids. However, the authors emphasized an important scientific caveat: the existing studies feature considerable heterogeneity in study designs and relatively small sample sizes, meaning that while the patterns are encouraging, larger trials are needed before drawing firm, uniform conclusions across different product types.

Individual clinical trials provide more specific detail on how these products perform over time. A double-blind, placebo-controlled trial published in 2025 tested a daily dose of 5,000 mg (5 grams) of bioactive collagen peptides in 77 healthy women over 12 weeks, followed by a 4-week washout period where no supplements were taken. Compared to the placebo group, participants taking the peptides experienced significant improvements in dermal density, skin hydration, and transepidermal water loss (TEWL), which measures how much moisture evaporates through the skin. Notably, these gains were largely retained four weeks after stopping the supplement, suggesting that the peptides supported structural changes rather than just transient moisture.

Other studies have evaluated different sources and particle sizes. A 2024 trial of 100 healthy adults assessed low-molecular-weight collagen peptides over 12 weeks. Researchers recorded significant reductions in average skin roughness, maximum wrinkle height, and peak-to-valley measurements compared to placebo. The test group also demonstrated notable improvements in skin elasticity, moisture levels, and visual measures of skin tone and redness.

Marine sources have shown similar outcomes in controlled settings. A 2024 double-blind trial evaluated tuna-derived collagen peptides in 72 women over an 8-week period, with a 2-week follow-up after stopping. The researchers documented significant increases in skin hydration, elasticity, and density, along with reductions in transepidermal water loss. As with the 2025 trial, the benefits remained detectable two weeks after participants stopped taking the supplement.

Barrier Support and Sensitive Skin

Beyond general skin aging, researchers have begun investigating whether oral peptides can assist the skin barrier during periods of chronic irritation.

A 2026 randomized, placebo-controlled trial published in Skin Pharmacology and Physiology examined 12 weeks of daily oral bioactive collagen peptides (5 grams daily) in adults managing moderate atopic dermatitis, a condition characterized by a compromised skin barrier and severe itch.

Participants taking the collagen peptides demonstrated a significant reduction in their need for topical corticosteroid rescue medication compared to the placebo group. They also experienced an earlier reduction in itchiness on clinical pruritus scales by week 4, improved hydration in affected skin patches, and better maintenance of the skin's natural acidic pH (4.5 to 5.5). The authors noted that while these results offer promising evidence for supporting barrier recovery, they represent an initial clinical finding that still requires confirmation in larger study populations.

If you have a chronic skin condition or use prescription topical medications, talk to your doctor or pharmacist before introducing new dietary supplements into your routine.

What the Evidence Shows for Joint Comfort

Collagen is also widely used for joint care, particularly for wear-and-tear discomfort in weight-bearing joints such as the knees. In joint cartilage, type II collagen provides the primary tensile framework.

A 2023 randomized, double-blind clinical trial published in Nutrition Journal investigated the effects of hydrolyzed type II collagen in 160 older adults diagnosed with grade 1 to 3 knee osteoarthritis and persistent joint pain lasting at least three months. The study divided participants into four groups receiving hydrolyzed type II collagen alone, a combination formula containing hydrolyzed type II collagen with chicken essence, glucosamine hydrochloride, or a placebo for 24 weeks. All participants took part in a concurrent resistance training program.

At the end of the 24-week intervention, all four groups showed similar improvements on the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC), a standard tool used to assess joint pain, stiffness, and physical ability. Because the placebo group also participated in resistance training and improved, the study showed that collagen did not outperform exercise for long-term functional scores.

However, the hydrolyzed type II collagen group did show a distinct short-term benefit: participants taking it experienced a statistically significant reduction in joint pain scores on a visual analogue scale (VAS) at day 14 compared to the placebo group. The group taking the combination formula also exhibited higher fat-free mass and improved grip strength compared to the glucosamine group at week 24, suggesting possible nutritional support for muscle maintenance during exercise.

Practical Takeaways for Shoppers

When evaluating collagen supplements, keeping the clinical evidence in perspective helps set realistic expectations:

Clinical trials have reported that collagen peptides are well tolerated, with no significant product-related adverse events identified in the reviewed studies. However, individuals with fish or poultry allergies should carefully verify the source of the collagen listed on the label. As with any new supplement, talk to your doctor or pharmacist if you take regular medications, are managing a medical condition, or are pregnant or breastfeeding.

Compare the picks: Best supplements for Joints, Muscles & Bones

Sources

These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease. This guide offers general product suggestions, not medical advice. Talk to your healthcare provider before starting supplements, especially if you are pregnant, nursing, or take medication.